COLUMBUS, Ohio (WCMH) — Girls at Hilltonia Middle School got a hands-on experience in health care science Tuesday. After ...

A South Korean life sciences company plans to open a genetic testing lab in North Austin, a move that could create up to 200 jobs. Last week, the Austin City Council approved a $200,000 economic ...

Dr. Cindi Love, Executive Director of Out for Undergrad, emphasized the significance of Valladares’ appointment: ...

Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue? Over the past ...

Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2025 Earnings Call Transcript February 10, 2026 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $1.86, expectations were $1.81. Rebecca: ...

GIlead Sciences (GILD) stock is trading at record highs after announcing a top- and bottom-line beat for the fourth quarter ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...